The Latest in Cythemias

JAK inhibition linked to B-cell lymphoma

July 5, 2018

Ropeg outperforms HU in PV patients of all ages

June 28, 2018

Cythemias

Umbralisib can revitalize ruxolitinib in MF

June 20, 2018

Cythemias

PU-H71 receives orphan drug designation for myelofibrosis

June 15, 2018

How ruxolitinib reduces thrombosis in MPNs

May 8, 2018

Pacritinib bests BAT, doesn’t seem to affect survival

March 12, 2018

Cythemias

New mutation linked to familial erythrocytosis

March 11, 2018

Cythemias

FDA approves test to diagnose MPNs

January 25, 2018

Cythemias

DNA methylation may predict outcomes in JMML

January 11, 2018

Team develops new scoring systems for PMF

December 27, 2017

Cythemias

Drug allows for treatment-free periods in PV

December 21, 2017

Cythemias

Allo-HSCT leads to long-term survival in MF

December 20, 2017

Ruxolitinib improves survival for MF patients in CP-e

December 18, 2017

Cythemias

CHMP recommends generic drug for ET

December 17, 2017

Plek2 may be therapeutic target in MPNs

December 3, 2017

Cythemias